Sequencing identifies multiple early introductions of SARS-CoV-2 to the New York City region

  1. Adriana Heguy2,3
  1. 1Institute for Systems Genetics, NYU Grossman School of Medicine, New York, New York 10016, USA;
  2. 2Department of Pathology, NYU Grossman School of Medicine, New York, New York 10016, USA;
  3. 3Genome Technology Center, Division of Advanced Research Technologies, Office of Science and Research, NYU Langone Health, New York, New York 10016, USA;
  4. 4Center for Biospecimen Research and Development, NYU Langone Health, New York, New York 10016, USA;
  5. 5MRC Centre for Global Infectious Disease Analysis and Department of Infectious Disease Epidemiology, Imperial College London, London W2 1PG, United Kingdom;
  6. 6Department of Dermatology, NYU Grossman School of Medicine, New York, New York 10016, USA;
  7. 7Medical Center IT, NYU Langone Health, New York, New York 10016, USA;
  8. 8Division of Infectious Diseases and Immunology, Department of Medicine and NYU Langone Vaccine Center, NYU Grossman School of Medicine, New York, New York 10016, USA
  • Corresponding authors: maurano{at}nyu.edu, matija.snuderl{at}nyulangone.org, adriana.heguy{at}nyulangone.org
  • Abstract

    Effective public response to a pandemic relies upon accurate measurement of the extent and dynamics of an outbreak. Viral genome sequencing has emerged as a powerful approach to link seemingly unrelated cases, and large-scale sequencing surveillance can inform on critical epidemiological parameters. Here, we report the analysis of 864 SARS-CoV-2 sequences from cases in the New York City metropolitan area during the COVID-19 outbreak in spring 2020. The majority of cases had no recent travel history or known exposure, and genetically linked cases were spread throughout the region. Comparison to global viral sequences showed that early transmission was most linked to cases from Europe. Our data are consistent with numerous seeds from multiple sources and a prolonged period of unrecognized community spreading. This work highlights the complementary role of genomic surveillance in addition to traditional epidemiological indicators.

    Footnotes

    • [Supplemental material is available for this article.]

    • Article published online before print. Article, supplemental material, and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.266676.120.

    • Freely available online through the Genome Research Open Access option.

    • Received August 3, 2020.
    • Accepted October 20, 2020.

    This article, published in Genome Research, is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.

    | Table of Contents
    OPEN ACCESS ARTICLE

    This Article

    1. Genome Res. 30: 1781-1788 © 2020 Maurano et al.; Published by Cold Spring Harbor Laboratory Press

    Article Category

    ORCID

    Share

    Preprint Server